Patents Without Patents

Regulatory Incentives for Innovation in the Drug Industry
Couldn’t attend the event? Check out the video of the event and select speakers’ slides below!
In the pharmaceutical industry, patents are the preeminent incentive for innovation in developing new drugs. But patents aren’t the whole story; regulatory agencies also offer different forms of exclusivity—enforced by the agencies themselves—to encourage different forms of innovation in the industry. This panel discussed actual and potential roles for those rewards in the context of developing new drugs, new uses for old drugs, and new ways to make drugs, in both the United States and the European Union. Panelists were:
Learn More
Video:

Select Speakers’ Slide Presentations:
For questions, contact petrie-flom@law.harvard.edu or 617-495-2316.